Abstract:Background and purpose Previous studies have shown that the mean dose to the parotid gland stem cell rich regions (D mean,SCR ) is the strongest dosimetric predictor for the risk of patient-reported daytime xerostomia. This study aimed to test whether the relationship between patient-reported xerostomia and D mean,SCR is explained by a dose-dependent reduction of saliva production. Material/methods In 570 head and neck cancer patients treated with definitive radiation therapy (RT), flow from the parotid (FLOW PAR ) and submandibular/sublingual glands (FLOW SMSL ) and patient-reported daytime (XER DAY ) and nighttime xerostomia (XER NIGHT ) were prospectively measured before, and at 6 and 12 months after RT. Using linear mixed effect models, the relations of mean dose to the parotid glands (D mean,par ), D mean,SCR , non-SCR parotid gland tissue (D mean,non-SCR ), submandibular glands (D mean,sub ) and oral cavity (D mean,oral ) with salivary flow and xerostomia were analyzed while correcting for known confounders. Results D mean,SCR proved to be responsible for the effect of D mean,par on FLOW PAR (p≤0.03), while D mean,non-SCR did not affect FLOW PAR (p≥0.11). To illustrate, increasing D mean,SCR by 10 Gy at fixed D mean,non-SCR , reduced FLOW PAR by 0.02 (25%) after RT. However, if the opposite happened, no change in FLOW PAR was observed (0.00 ml/min [4%]). As expected, D mean,sub was significantly associated with FLOW SMSL (p<0.001). For example, increasing D mean,sub by 10 Gy, reduced FLOW SMSL with 0.07 ml/min (26%) after RT. Xerostomia scores were also affected by dose to the salivary glands. D mean,SCR and D mean,oral were associated with higher XER DAY scores (p≤0.05), while D mean,sub increased XER NIGHT scores (p=0.01). For example, an increase of 10 Gy in D mean,SCR raised XER DAY scores with 2.13 (5%) points after RT, while an additional 10 Gy in D mean,subs increased XER NIGHT scores with 2.20 points (6%) after RT. Salivary flow was not only associated with radiation dose, but also with xerostomia scores in line with the salivary glands' functions, i.e., FLOW PAR only influenced XER DAY (p<0.001, 10.92 points lower XER DAY per 1 ml/min saliva), while FLOW SMSL affected XER DAY and XER NIGHT (p≤0.004, 6.69 and 5.74 points lower XER DAY and XER NIGHT , respectively, per 1 ml/min saliva). Therefore, the observed relations between dose and xerostomia were corrected for salivary flow. As hypothesized, D mean,SCR only increased XER DAY scores via reducing FLOW PAR ; whereas the effects of D mean,oral on XER DAY and of D mean,sub on XER NIGHT were independent of salivary flow. Conclusion Higher SCR region dose reduced parotid gland saliva production, subsequently resulting in higher daytime xerostomia scores. Consequently, this study supports the clinical implementation of stem cell sparing RT to preserve salivary flow with the aim of reducing the risk of xerostomia.

Impact of Salivary Gland Dosimetry on Post-Imrt Recovery of Saliva Output and Xerostomia Grade for Head-and-neck Cancer Patients Treated with or Without Contralateral Submandibular Gland Sparing: a Longitudinal Study.

Oncological Outcome of Patients with Salivary Gland Cancer Treated with Surgery and Postoperative Intensity-Modulated Radiotherapy: a Retrospective Study

[The Relationship Between the Parotid Glands Function and the Dose-Volume Effect in Nasopharyngeal Carcinoma Patients with Intensity-Modulated Radiation Therapy].

Reducing Xerostomia by Comprehensive Protection of Salivary Glands in Intensity-Modulated Radiation Therapy with Helical Tomotherapy Technique for Head-and-Neck Cancer Patients: A Prospective Observational Study.

The Impact of Submandibular Glands Protection on Xerostomia As Monitored by Diffusion-Weighted Imaging in Nasopharyngeal Carcinoma Patients.

Long-term outcomes of stimulated salivary flow and xerostomia after definitive intensity-modulated radiation therapy for patients with head and neck cancerâ€

Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival

Submandibular salivary gland transfer for the prevention of radiation-induced xerostomia in patients with nasopharyngeal carcinoma: 5-Year outcomes.

Effect of dose to parotid ducts on Sticky Saliva and Xerostomia in radiotherapy of head and neck squamous cell carcinoma

Radiation‐induced Volume Changes in Parotid and Submandibular Glands in Patients with Head and Neck Cancer Receiving Postoperative Radiotherapy: A Longitudinal Study

Impact on xerostomia for patients with nasopharyngeal carcinoma treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A prospective phase II randomized controlled study.

Sparing Submandibular Gland to Alleviating Acute Xerostomia in Patients with Nasopharyngeal Carcinoma Treated with Helical Tomotherapy: Evaluation by Diffusion Kurtosis Imaging

Protective effect of intensity-modulated radiation therapy on salivary gland function in nasopharyngeal carcinoma patients

Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation

Outcomes and Xerostomia after Postoperative Radiotherapy for Oral and Oropharyngeal Carcinoma

Effects of an integrated supportive program on xerostomia and saliva characteristics in patients with head and neck cancer radiated with a low dose to the major salivary glands: a randomized controlled trial

Submandibular Gland Transfer Prevents Radiation-Induced Xerostomia

[Primary Effect of Submandibular Salivary Gland Transfer in Preventing Radiation-Induced Xerostomia of Nasopharyngeal Carcinoma].

Assessment and Prediction of Salivary Gland Function After Head and Neck Radiotherapy: A Systematic Review

IMRT for Head and Neck Cancer: Reducing Xerostomia and Dysphagia.

Radiation-induced xerostomia is related to stem cell dose-dependent reduction of saliva production